Highlights
Research from the CHAMP1ON cohort reveals that a low 24-hour heart rate standard deviation (SD < 30.4 bpm) doubles the risk of cardiovascular mortality in patients with diabetes over a two-decade follow-up period.
Blunted nocturnal heart rate dipping (less than 10%) is associated with a 63% increase in cardiovascular mortality and a significantly higher prevalence of cardiac autonomic neuropathy and nephropathy.
Heart rate metrics derived from standard ambulatory blood pressure monitoring (ABPM) provide a widely available and inexpensive method for long-term risk stratification in metabolic disease.
Introduction: The Burden of Autonomic Dysfunction in Diabetes
Diabetes mellitus, both Type 1 and Type 2, is characterized by a high burden of cardiovascular complications. While traditional risk factors such as hyperglycemia, hypertension, and dyslipidemia are routinely managed, the role of the autonomic nervous system in predicting long-term outcomes is often overlooked in clinical practice. Cardiac autonomic neuropathy (CAN) is a serious but underdiagnosed complication of diabetes, reflecting damage to the autonomic nerve fibers that regulate heart rate and vascular tone. Traditionally, CAN is diagnosed through specialized heart rate variability (HRV) tests or cardiovascular autonomic reflex tests (CARTs), which may not be readily available in all clinical settings. However, circadian heart rate fluctuations—observable through standard 24-hour monitoring—offer a window into the integrity of the autonomic system. This study examines how these fluctuations serve as long-term predictors of survival.
Study Design: Longitudinal Insights from the CHAMP1ON Cohort
This study represents a secondary analysis of the CHAMP1ON (Cardiovascular Health and Metabolic Profile in One Nation) cohort. The analysis focused on 349 participants with either Type 1 or Type 2 diabetes who underwent baseline 24-hour ambulatory blood pressure and heart rate monitoring (ABPM). The primary objective was to evaluate the relationship between circadian heart rate (HR) fluctuations and survival over an exceptionally long follow-up period, averaging 21 years.
Two primary metrics were used to define impaired circadian HR fluctuations: a low 24-hour HR standard deviation (SD), defined as being below the cohort median of 30.4 bpm, and a blunted nocturnal HR dip, defined as a reduction in heart rate during sleep of less than 10% compared to daytime values. The researchers examined these metrics in relation to clinical features, microvascular complications, and mortality rates (both cardiovascular and all-cause).
Key Findings: Quantifying the Risk of Blunted Fluctuations
The study yielded robust data after 6,251 person-years of follow-up. A total of 136 deaths (39% of the cohort) occurred, with cardiovascular causes accounting for 68% of these fatalities. The results highlighted a stark contrast in survival based on heart rate dynamics.
24-Hour Heart Rate Standard Deviation
Participants in the low 24-hour HR SD group exhibited a significantly higher risk profile. After adjusting for confounding variables, this group had an adjusted hazard ratio (aHR) of 2.00 (95% CI 1.30–3.08, P = 0.002) for cardiovascular mortality compared to those with high HR SD. All-cause mortality was also significantly higher in this group (aHR 1.61, 95% CI 1.13–2.29, P = 0.009).
Nocturnal Heart Rate Dipping
Similar patterns were observed regarding nocturnal dipping. Patients with a blunted nocturnal HR dip (<10%) faced a higher risk for cardiovascular mortality (aHR 1.63, 95% CI 1.08–2.46, P = 0.019) and all-cause mortality (aHR 1.69, 95% CI 1.20–2.38, P = 0.003) compared to those with a preserved dip. These findings suggest that the loss of the physiological drop in heart rate during sleep is a marker of severe autonomic impairment and poor long-term prognosis.
Association with Microvascular Disease
Beyond mortality, impaired circadian HR fluctuations were closely linked to existing microvascular damage. Patients with low HR SD and blunted dipping showed a 12-23% higher prevalence of cardiac autonomic neuropathy and diabetic nephropathy at baseline. This suggests that the heart rate metrics are not only predictive of future events but also reflective of the current extent of systemic microvascular damage in patients with diabetes.
Mechanistic Insights: The Vagal-Vascular Connection
The physiological basis for these findings lies in the balance between the sympathetic and parasympathetic nervous systems. In healthy individuals, the heart rate exhibits significant variability and a pronounced dip during sleep, primarily driven by increased vagal (parasympathetic) tone and reduced sympathetic activity. In diabetes, chronic hyperglycemia and oxidative stress lead to nerve fiber damage, specifically affecting the vagus nerve early in the disease process. This results in a relatively higher nocturnal heart rate and reduced overall fluctuation (tachycardia and “fixed” heart rate). This autonomic imbalance promotes pro-inflammatory states, increases cardiac workload, and accelerates vascular aging, ultimately leading to the increased mortality rates observed in the study.
Expert Commentary: Clinical Utility of ABPM-Derived Heart Rate
The clinical significance of this study lies in the accessibility of the data. While high-resolution HRV analysis requires specialized equipment and software, 24-hour heart rate monitoring is a standard component of ABPM, which is already frequently used to manage hypertension in diabetic patients. Clinicians can easily extract the heart rate SD and calculate the nocturnal dip from these reports without additional cost or patient burden. Identifying a “non-dipping” heart rate pattern should alert the clinician to a higher risk of autonomic neuropathy and the need for more aggressive cardiovascular risk management.
Conclusion
The 21-year CHAMP1ON cohort analysis confirms that impaired circadian heart rate fluctuations are a potent, independent predictor of long-term mortality in diabetes. Both a low 24-hour HR SD and a blunted nocturnal dip serve as critical indicators of autonomic dysfunction and microvascular disease. Incorporating these HR measures into routine risk stratification could significantly improve the identification of high-risk patients, allowing for earlier intervention in a population already vulnerable to cardiovascular complications.
References
Nesti L, Chiriacò M, Sacchetta L, et al. Circadian heart rate fluctuations predict cardiovascular and all-cause mortality in type 2 and type 1 diabetes: a 21-year retrospective longitudinal study. Eur J Prev Cardiol. 2026 Jan 6;33(1):101-110. doi: 10.1093/eurjpc/zwae305. PMID: 39325931.
